Across TCGA pan-cancer cohorts, HNRNPA3P15 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated HNRNPA3P15 data layer.
The strongest signal is observed in uterine carcinosarcoma (UCS), where higher HNRNPA3P15 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated HNRNPA3P15 expression acts as an unfavorable survival marker, although some lineages such as UCS and READ show a favorable association.
UCS, READ, and LGG are the cancer types where HNRNPA3P15 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.